E. C. Keeley, J. A. Boura, and C. L. Grines, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials, Lancet, vol.361, pp.13-20, 2003.

P. W. Armstrong, A. H. Gershlick, P. Goldstein, R. Wilcox, T. Danays et al.,

K. , G. S. Fresco, C. Bluhmki, E. Regelin, A. Vandenberghe et al., Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction, STREAM Investigative Team, vol.368, pp.1379-1387, 2013.

N. Danchin, D. Blanchard, P. G. Steg, P. Sauval, G. Hanania et al., Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC, Registry. Circulation, vol.110, pp.1909-1915, 2000.

E. Bonnefoy, P. G. Steg, F. Boutitie, P. Y. Dubien, F. Lapostolle et al., Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction
URL : https://hal.archives-ouvertes.fr/hal-00539344

, Eur Heart J, vol.30, pp.1598-1606, 2009.

E. Boersma, A. C. Maas, J. W. Deckers, and M. L. Simoons, Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, vol.348, pp.771-775, 1996.

K. P. Alexander, L. K. Newby, P. W. Armstrong, C. P. Cannon, W. B. Gibler et al., Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology, Circulation, vol.115, pp.2570-2589, 2007.

A. Rosengren, L. Wallentin, M. Simoons, A. K. Gitt, S. Behar et al., Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey, Eur Heart J, vol.27, pp.789-795, 2006.

O. Koeth, R. Zahn, A. K. Gitt, T. Bauer, C. Juenger et al., Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry), Am J Cardiol, vol.104, pp.1074-1077, 2009.

B. Ibanez, S. James, S. Agewall, M. J. Antunes, C. Bucciarelli-ducci et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.39, pp.119-177, 2017.

V. Auffret, Y. Cottin, G. Leurent, M. Gilard, J. C. Beer et al.,

R. Zeller, M. , L. Breton, and H. , Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score, Eur Heart J, vol.39, pp.2090-2102, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01833100

K. Thygesen, J. S. Alpert, A. S. Jaffe, B. R. Chaitman, J. J. Bax et al., White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction, Eur Heart J, vol.40, pp.237-269, 2019.

P. G. Steg, S. K. James, D. Atar, L. P. Badano, C. Blömstrom-lundqvist et al.,

K. Huber, P. Juni, A. Kastrati, J. Knuuti, M. J. Lenzen et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.33, pp.2569-2619, 2012.

G. Heinze and P. Jüni, An overview of the objectives of and the approaches to propensity score analyses, Eur Heart J, vol.32, pp.1704-1708, 2011.

P. Widimsky, W. Wijns, J. Fajadet, M. De-belder, J. Knot et al., Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, vol.31, pp.943-957, 2010.

L. Belle, G. Cayla, Y. Cottin, P. Coste, K. Khalife et al., Danchin N; FAST-MI 2015 investigators. French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction, Arch Cardiovasc Dis, vol.110, pp.366-378, 2015.

H. Bueno, A. Betriu, M. Heras, J. J. Alonso, A. Cequier et al., Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies, Eur Heart J, vol.32, pp.51-60, 2011.

P. G. Steg, E. Bonnefoy, S. Chabaud, F. Lapostolle, P. Y. Dubien et al., Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial, Circulation, vol.108, pp.2851-2856, 2003.

V. Auffret, G. Leurent, M. Gilard, J. P. Hacot, E. Filippi et al.,

M. Guellec, D. E. , L. Breton, and H. , Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention, Int J Cardiol, vol.221, pp.433-442, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01372350

D. S. Pinto, A. J. Kirtane, B. K. Nallamothu, S. A. Murphy, D. J. Cohen et al., Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, vol.114, pp.2019-2025, 2006.

, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, GUSTO Angiographic Investigators, vol.329, pp.1615-1622, 1993.

B. K. Nallamothu, E. R. Bates, J. Herrin, Y. Wang, E. H. Bradley et al., Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis, Circulation, vol.111, pp.761-767, 2005.

K. Goel, D. S. Pinto, and C. M. Gibson, Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review, Am Heart J, vol.165, pp.451-467, 2013.

T. J. Siddiqi, M. S. Usman, M. S. Khan, J. Sreenivasan, I. Kassas et al., Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial Infarction, Am J Cardiol, vol.122, pp.542-547, 2018.

P. W. Armstrong, Y. Zheng, C. M. Westerhout, F. Rosell-ortiz, P. Sinnaeve et al.,

B. E. Rd, T. Danays, and F. Van-de-werf, Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial, Am Heart J, vol.169, pp.890-898, 2006.

, Body-mass index (kg/m²) 26

, Hypertension, vol.142

, Glycemia on admission, p.2443

, Symptoms onset-to-FMC delay (min) Symptoms onset-to-FMC delay, vol.180, pp.60-200

, Clopidogrel, vol.261

, Statins, vol.232

, Categorical variables are presented as numbers (percentage)

, ACE= Angiotensin Converting enzyme

, ARB= Angiotensin Receptor Blockers